Author

Jillian M. Jespersen

University of California, San FranciscoORCID 0000-0002-8231-6978Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adil E. WakiliD· 1 shared Alexis J. CombesiD· 1 shared Ann L. EricksoniD· 1 shared Arjun Arkal RaoiD· 1 shared Austin W. EdwardsiD· 1 shared Christopher P. LooiD· 1 shared Gabriela K. FragiadakisiD· 1 shared Gavin ClohertyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adil E. WakilORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4+ T cell responses

Jillian M. Jespersen, Lia Avanesyan, Jean Publicover, Nicholas D. Carey, Ravi K. Patel, Austin W. Edwards, Sarah Stenske, Jae Hyun Shin, Jiajing Li, Margaret Simone, Nayvin W. Chew, Nicholas Wong, Suprita Trilok, Ann L. Erickson, Arjun Arkal Rao, , Jody L. Baron

The paper identifies shared mechanisms of HBsAg seroclearance using a mouse model and longitudinal PBMCs from CHB patients, showing CD4+ T cell activation is essential for clinical cure.

bioRxiv · Sep 29, 2025 · PreprintImmunology